Consumer resistance to frozen foods driven by health fears, new study finds

Published Date: 02 May 2025

Concerns over health and freshness are keeping many shoppers from embracing frozen foods, a new study suggests—despite their potential to reduce food waste, cut carbon footprints, and offer affordable nutrition.

Read Full News

Latest News

Q3 2026 Preview: 4 FDA Decisions to Watch

Q3 2026 Preview: 4 FDA Decisions to Watch

FDA Grants Accelerated Approval to Navepegritide for Achondroplasia in Children Aged 2 Years and Older

FDA Grants Accelerated Approval to Navepegritide for Achondroplasia in Children Aged 2 Years and Older

GLP-1s Are Treating a Diagnosis. Who’s Treating the Patient?

Without nutrition and eating disorder support, clinicians prescribing GLP-1s may miss undernutrition, muscle loss, and harmful restriction.

High-Dose Probiotic Helps Patients With Chronic Diarrhea

A high-dose eight-strain probiotic is linked to a decrease in the percentage of fecal primary bile acids among patients with bile acid malabsorption.

3 Common Drugs Older Adults Might Be Overusing

Recent studies of three medications or classes of drugs widely used among older Americans illustrate the problem.

Standing Up More May Not Cut Risk for Cancer Death

Only replacing sitting with physical activity seems to help.

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Latest News

Q3 2026 Preview: 4 FDA Decisions to Watch

FDA Grants Accelerated Approval to Navepegritide for Achondroplasia in Children Aged 2 Years and Older

Without nutrition and eating disorder support, clinicians prescribing GLP-1s may miss undernutrition, muscle loss, and harmful restriction.

A high-dose eight-strain probiotic is linked to a decrease in the percentage of fecal primary bile acids among patients with bile acid malabsorption.

Recent studies of three medications or classes of drugs widely used among older Americans illustrate the problem.

Only replacing sitting with physical activity seems to help.

News All Time

Reducing Infusion Wait Times at VA New Jersey

VA New Jersey slashed chemo infusion wait times 32% — from 164 to 106 minutes — through order templates, pre-visit bloodwork, and a fast-track room.

Evaluating the Implementation of 60-Minute Iron Infusions

Safe 60-minute iron dextran infusion protocol has been demonstrated at large institutions, but its impact on patient safety at small, rural clinics has not been reported.

Hospital Outcomes Associated With SUDs in Pancreatic Cancer

This project sought to evaluate the impact of substance use disorders on inpatient outcomes among hospitalized patients with pancreatic cancer.

Expanding CoC Standard 5.9

Smoking cessation improves treatment response and survival, while reducing recurrence and complications in cancer patients.

Cannabis Edibles Impair Driving Even Below Legal THC Limits

Cannabis edibles dose-dependently impair simulated driving performance hours after ingestion at THC blood concentrations below roadside enforcement levels.

Pollutant Exposure Tied to Increased Suicide Risk

Air pollutant exposure, especially to PM2.5, PM10, and nitrogen dioxide, is associated with increased risk for death by suicide, attempted suicide, and suicidal ideation.

Does Sex Factor in the Obstetrical Dilemma?

Baby boys tend to be larger at birth than girls. New research asks whether those differences may help explain more challenging deliveries.

SLE Linked to Increased Risk for Stroke

Patients with systemic lupus erythematosus face a substantially elevated risk for ischemic and hemorrhagic stroke compared with control individuals, a meta-analysis shows.

Shingles Vaccine Boosts Antibodies in People Living With HIV

A recombinant zoster vaccine builds strong antibody protection in people living with HIV, regardless of their CD4 count — but their cellular immune response still lags behind those without HIV.

Remote Videos Can Reliably Flag Cerebral Palsy Risk

Remote video-based assessment at 3-4 months of corrected age can reliably flag the risk for cerebral palsy in infants born very preterm.

Primary Care Quality Tied to Hospital Use in Multimorbidity

In patients with multimorbidity, better primary care checks increase the odds of outpatient and emergency care, but multimorbidity-specific checks lower the odds of elective hospital admissions.

AI in Gastroenterology: Benefits vs Harms

AI applications are poised to become the mandated standard of practice in gastroenterology, and in some institutions already are.

Esophagitis Dissecans Superficialis in Woman With Dysphagia

A woman presents with progressive dysphagia and vomiting; endoscopy reveals extensive esophageal mucosal sloughing consistent with esophagitis dissecans superficialis.

Laughter Really Is The Best Medicine

The data on laughter are more serious than you’d expect. Dr Neil Skolnik breaks down the physiological benefits of humor.

AI in Medicine Reduces Burden, Not Judgment

AI in medicine isn’t about replacing clinical reasoning. It’s about freeing up physicians to do more of what only they can do.

Gaps in Access to Maternity Care Tied to Labor Induction

Maternal residence in rural, lower-access counties is associated with an increased risk for labor induction at full term.

Recommended News For You

ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types

Race, Geography Linked to Gaps in Prostate Cancer Care

Novel probes to label macrophages associated with cancer progression using a selective dye

Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

Time to Rethink Maintenance Pemetrexed in NSCLC?

Long-term study links chronic conditions in midlife to higher cancer risk and mortality

Recommended Articles For You

Exploring the Latest Advances in Hodgkin's Lymphoma Treatment 

Circulating Tumor DNA Dynamics for Therapy Matching: A Comprehensive Clinical Review 

Quality of Life Through Personalized Survivorship Navigation After Multimodal Cancer Therapy 

Screening for Early Changes in Blood-Cell Production Capacity in Older Adults 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TULSA Is Effective in Long-Term Prostate Cancer Control.

2.

AVD Chemo Regimen Shows Promise in Older Patients With HL

3.

Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

4.

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

5.

New Nanoparticles Can Destroy Undruggable Cancer Proteins

1.

Programmable Cell Therapies for Selective Removal of Dysfunctional Hematopoietic Cell Populations

2.

Contemporary Insights in Oncology in the Digital Era

3.

Strategic Concepts in Hematology for Modern Medicine

4.

Ferroptosis-Modulating Therapeutics in Precision Oncology

5.

Exploring the Potential of Bendamustine in Cancer Treatment

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

1.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

2.

Blood Clotting Disorders Explained

3.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

4.

Chemotherapy: What to Expect

5.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot